4//SEC Filing
Bay City Capital Fund V, L.P. 4
Accession 0001209191-10-036694
CIK 0001061027other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 7:58 PM ET
Size
21.1 KB
Accession
0001209191-10-036694
Insider Transaction Report
Form 4
BAY CITY CAPITAL LLC
10% Owner
Transactions
- Purchase
Common Stock
2010-06-30$0.28/sh+445,516$122,517→ 632,416 total - Conversion
Common Stock
2010-06-30+9,808,090→ 9,808,090 total - Purchase
Common Stock
2010-06-30$0.28/sh+23,378,934$6,429,207→ 33,187,024 total - Conversion
Common Stock
2010-06-30+186,900→ 186,900 total - Conversion
Series A Preferred Stock
2010-06-30$2.20/sh−980,809$2,157,780→ 0 totalExercise: $0.00From: 2010-06-30→ Common Stock (9,808,090 underlying) - Conversion
Series A Preferred Stock
2010-06-30$2.20/sh−18,690$41,118→ 0 totalExercise: $0.00From: 2010-06-30→ Common Stock (186,900 underlying)
Holdings
- 9,091
Common Stock
Footnotes (6)
- [F1]Each one (1) share of Series A Preferred Stock was converted into ten (10) shares of Common Stock upon the Issuer's common equity closing (as defined in the applicable Certificate of Designation).
- [F2]Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"), Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Management V is the general partner of Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V.
- [F3]Represent securities held by Fund V, including indirect interests of BCC and Management V. BCC and Management V each disclaim beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
- [F4]Represent securities held by Co-Investment V, including indirect interests of BCC and Management V. BCC and Management V each disclaim beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
- [F5]BCC is the sole owner of these shares.
- [F6]Not applicable.
Documents
Issuer
SUNESIS PHARMACEUTICALS INC
CIK 0001061027
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001401826
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 7:58 PM ET
- Size
- 21.1 KB